Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and ...

RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, announced today the close of a $15 million Series A financing co-led by SPRIM ...

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

Anemia is prevalent among patients with rheumatoid arthritis, according to study findings published in Cureus.

Rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) belong to the most common chronic inflammatory diseases (CIDs). While significant research efforts have led to improvements in treatment, ...

A study published in Cureus has highlighted the high prevalence of anemia among patients with rheumatoid arthritis (RA).

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

My dentist explained that using a water flosser lessens the amount of fine motor movement necessary to get in between teeth.

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...

International research team, which includes UNIGE researchers, aims to advance risk prediction, early detection of disease ...

The word “arthritis” describes pain, stiffness, and swelling in the joints. It can be a bit of a nuisance or extremely ...